Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Join | Sign in

  News Archive

Evoke Pharma Achieves Significant Manufacturing Milestone
Thursday, April 16, 2015
Manufacturing program includes three year registration stability data.

Recro Pharma Completes Acquisition of Assets from Alkermes plc
Thursday, April 16, 2015
Phase III-ready, long-acting injectable meloxicam has demonstrated robust efficacy, good tolerability in multiple Phase II trials.

Recipharm Makes Strategic Investment in Synthonics
Wednesday, April 15, 2015
Recipharm has purchased $2.0 million of preferred stock in the company.

Mechanism of Action of ABIVAX’s First-in-class Anti-HIV Drug Published
Wednesday, April 15, 2015
Novel mechanism of action - prevention of viral RNA exit from nucleus of infected cells - associated to unique anti-viral properties.

CMXC Announces Additional Results of Preliminary Analysis of Metabolomic Assays
Wednesday, April 15, 2015
New findings reveal enhanced transport as well as utilization of glucose during a treatment.

MorphoSys to Receive Milestone Payment for Guselkumab Program
Tuesday, April 14, 2015
Company initiates phase 2 clinical trial in psoriatic arthritis with the HuCAL antibody.

ReNeuron Files Application to Commence Phase I/II Clinical Trial in the US
Tuesday, April 14, 2015
IND application to commence clinical trial for retinitis pigmentosa with hRPC therapy candidate.

ThromboGenics and VIB Launch New Oncology Company
Tuesday, April 14, 2015
Oncurious NV to develop TB-403 for pediatric brain tumors.

Cipher Acquires INNOCUTIS Holdings, Licensee of Sitavig® in the USA
Tuesday, April 14, 2015
Acquisition will further strengthen Sitavig®'s position.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 3495

SELECTBIO Market Reports
Go to LabTube
Go to eposters